Mobiquity Technologies (MOBQ) insider reports 250,000 new options
Rhea-AI Filing Summary
Mobiquity Technologies, Inc. director and 10% owner Gene Salkind reported receiving new stock options linked to the company’s common stock. On 12/31/2025, he acquired options to purchase 250,000 shares of common stock at an exercise price of $1.10 per share, exercisable beginning 12/31/2025 and expiring on 12/31/2030.
After this grant, Salkind beneficially owned derivative securities tied to 761,544 shares of Mobiquity common stock. This total includes warrants, multiple option grants with exercise prices ranging from $0.20 to $68.48 per share, and a convertible note covering 100,000 shares at $1.00 per share.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did MOBQ disclose in this Form 4?
Mobiquity Technologies, Inc. disclosed that director and 10% owner Gene Salkind acquired options to purchase 250,000 shares of common stock on 12/31/2025.
What is the exercise price and term of Gene Salkind’s new Mobiquity stock options?
The new options allow Gene Salkind to buy Mobiquity common stock at $1.10 per share, starting on 12/31/2025 and expiring on 12/31/2030.
How many Mobiquity-related derivative securities does Gene Salkind own after this transaction?
Following the reported transaction, Gene Salkind beneficially owned derivative securities tied to 761,544 shares of Mobiquity Technologies, Inc. common stock.
What types of Mobiquity securities are included in Gene Salkind’s 761,544-share derivative total?
The 761,544-share derivative total includes 59,211 shares underlying warrants, options with exercise prices of $68.48, $0.20, $2.45 and $1.10 per share, and 100,000 shares underlying a convertible note at $1.00 per share.
What is Gene Salkind’s relationship to Mobiquity Technologies (MOBQ)?
Gene Salkind is reported as both a Director and a 10% Owner of Mobiquity Technologies, Inc.
Was the Mobiquity Form 4 filed for one or multiple reporting persons?
The Form 4 was indicated as filed by one reporting person, identifying Gene Salkind as the sole reporting insider.